Swiss Re (VTX:SREN) has been given a CHF 107 target price by HSBC in a note issued to investors on Friday. The firm presently has a “buy” rating on the stock. HSBC’s target price suggests a potential upside of 13.28% from the stock’s current price.
Several other brokerages also recently commented on SREN. UBS Group set a CHF 86 target price on Swiss Re and gave the company a “sell” rating in a report on Thursday, November 30th. Goldman Sachs Group set a CHF 95 target price on Swiss Re and gave the company a “neutral” rating in a report on Monday, November 6th. Morgan Stanley set a CHF 108 target price on Swiss Re and gave the company a “buy” rating in a report on Monday, November 6th. Credit Suisse Group set a CHF 96 target price on Swiss Re and gave the company a “neutral” rating in a report on Wednesday. Finally, DZ Bank reaffirmed a “buy” rating on shares of Swiss Re in a report on Tuesday, January 16th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of CHF 96.84.
Shares of Swiss Re (SREN) opened at CHF 94.46 on Friday. Swiss Re has a fifty-two week low of CHF 81.65 and a fifty-two week high of CHF 95.30. The company has a market capitalization of $32,780.00 and a price-to-earnings ratio of 12.08.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.